If hunger remains problematic despite these measures, your GP may need to review your dose or investigate other contributing factors
Ethics Approval and Consent to Participate All protocols were approved by the Ethics Committee of Binzhou Medical University Hospital (Ethical Number: 20221014-22 and 20231208-50)
Every trial youve heard of SELECT [1], FLOW [2], SURPASS-CVOT [3] enrolled people with diabetes, obesity, kidney disease, or established heart disease
If your next scheduled dose is more than 48 hours away, take the missed dose immediately as you remember
Comput Biol Chem
More importantly for muscle-focused applications, the proportion of lean mass loss to total weight loss was similar to or better than other obesity treatments, with Retatrutide demonstrating significant improvements in total body fat mass reduction compared to both placebo and dulaglutide (a single-receptor GLP-1 agonist)